KRAS and familial pancreatic carcinoma: In a parallel study, we found that HEK293T cells with constitutively active RAS (RAS-V12) showed higher HPS expression upon p-STAT3 activation, suggesting that HPS may be downregulated by STAT3 and may contribute to KRAS-mutated pancreatic cancer cell proliferation.